- Home
- APLM vs EDTK Comparison
APLM vs EDTK Comparison
Compare APLM & EDTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLM
- EDTK
- Stock Information
- Founded
- APLM 2016
- EDTK 2013
- Country
- APLM United States
- EDTK China
- Employees
- APLM N/A
- EDTK N/A
- Industry
- APLM Blank Checks
- EDTK Other Consumer Services
- Sector
- APLM Finance
- EDTK Real Estate
- Exchange
- APLM Nasdaq
- EDTK Nasdaq
- Market Cap
- APLM 15.6M
- EDTK 16.5M
- IPO Year
- APLM N/A
- EDTK 2020
- Fundamental
- Price
- APLM $0.10
- EDTK $1.03
- Analyst Decision
- APLM Strong Buy
- EDTK
- Analyst Count
- APLM 2
- EDTK 0
- Target Price
- APLM $4.25
- EDTK N/A
- AVG Volume (30 Days)
- APLM 1.2M
- EDTK 18.0K
- Earning Date
- APLM 08-14-2024
- EDTK 12-31-2024
- Dividend Yield
- APLM N/A
- EDTK N/A
- EPS Growth
- APLM N/A
- EDTK N/A
- EPS
- APLM N/A
- EDTK N/A
- Revenue
- APLM $2,101,000.00
- EDTK $1,999,056.00
- Revenue This Year
- APLM N/A
- EDTK N/A
- Revenue Next Year
- APLM N/A
- EDTK N/A
- P/E Ratio
- APLM N/A
- EDTK N/A
- Revenue Growth
- APLM 70.54
- EDTK N/A
- 52 Week Low
- APLM $0.10
- EDTK $0.77
- 52 Week High
- APLM $1.79
- EDTK $1.34
- Technical
- Relative Strength Index (RSI)
- APLM 34.54
- EDTK 53.69
- Support Level
- APLM $0.11
- EDTK $0.95
- Resistance Level
- APLM $0.13
- EDTK $1.03
- Average True Range (ATR)
- APLM 0.01
- EDTK 0.05
- MACD
- APLM -0.00
- EDTK 0.01
- Stochastic Oscillator
- APLM 4.02
- EDTK 97.40
About APLM Apollomics Inc.
Apollomics Inc is an innovative clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company lead programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other advanced tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.
About EDTK Skillful Craftsman Education Technology Limited
Skillful Craftsman Education Technology Ltd provides online education and technology services in China. The services comprises of two aspects - Online vocational training and Virtual simulation experimental training. It covers a wide range of subjects, including mechanics, electronics, auto repair and construction. Majority of its revenues are generated from the People's Republic of China.